Pharma

Can benefit plans stomach the $77 million weight-loss drug bill?

Wegovy claims soared 91% in 2024 as insurers weigh coverage limits and rising plan costs

Can benefit plans stomach the $77 million weight-loss drug bill?

Users of competitor lost 50% more weight than those on Wegovy in trial

Wegovy drives 91% spike in Canadian drug claims while Zepbound outperforms in US clinical trial

Users of competitor lost 50% more weight than those on Wegovy in trial

High-cost drug claims and coverage surged in 2023: report

Canadian Drug Insurance Pooling Corporation members saved over $946 million in out-of-pocket drug costs through extended policy plans in 2023

High-cost drug claims and coverage surged in 2023: report

Drug experts criticize Canada's drug approval system

"The price thing is a red herring," says former Patented Medicine Prices Review Board head, calling out delays in drug approvals

Drug experts criticize Canada's drug approval system

Pharma giant's stock rises after strong Q4 results and 2025 sales forecast

Novo Nordisk faces pressure from Eli Lilly, but its latest earnings and sales outlook push shares higher

Pharma giant's stock rises after strong Q4 results and 2025 sales forecast

Improving the prior authorization process

Founder of PAFA highlights how they're helping to streamline the PA process for payers

Improving the prior authorization process